Allogeneic iNKT cell infusion

· Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic iNKT cell infusion, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer [NA]

See pricing